Trial of N-Acetyl-l-Leucine in Niemann–Pick Disease Type C

T Bremova-Ertl, U Ramaswami, M Brands… - … England Journal of …, 2024 - Mass Medical Soc
Abstract Background Niemann–Pick disease type C is a rare lysosomal storage disorder.
We evaluated the safety and efficacy of N-acetyl-l-leucine (NALL), an agent that potentially …

Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C

T Bremova-Ertl, J Claassen, T Foltan… - Journal of …, 2022 - Springer
Objective To investigate the safety and efficacy of N-acetyl-l-leucine (NALL) on symptoms,
functioning, and quality of life in pediatric (≥ 6 years) and adult Niemann–Pick disease type …

N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study

T Fields, T M. Bremova, I Billington, GC Churchill… - Trials, 2023 - Springer
Abstract Background Niemann-Pick disease type C (NPC) is a rare autosomal recessive
neurodegenerative lysosomal disease characterized by multiple symptoms such as …

Current advancements in therapy for Niemann-Pick disease: Progress and pitfalls

T Bremova-Ertl, S Schneider - Expert opinion on pharmacotherapy, 2023 - Taylor & Francis
ABSTRACT Introduction Niemann-Pick disease type C (NPC) is a rare, autosomal recessive,
lysosomal storage disorder. To combat the progressive neurodegeneration in NPC, disease …

Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials

M Cortina-Borja, D Te Vruchte, E Mengel… - Orphanet journal of rare …, 2018 - Springer
Abstract Background Niemann-Pick disease type C (NPC) is a lysosomal storage disease
with a heterogeneous neurodegenerative clinical course. Multiple therapies are in clinical …

Acetyl-dl-leucine in Niemann-Pick type C: A case series

T Bremova, V Malinová, Y Amraoui, E Mengel… - Neurology, 2015 - AAN Enterprises
Objective: To assess the effects of the modified amino acid acetyl-dl-leucine (AL) on
cerebellar ataxia, eye movements, and quality of life of patients with Niemann-Pick type C …

Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter …

M Pineda, K Juríčková, P Karimzadeh… - Orphanet Journal of …, 2019 - Springer
Abstract Background Niemann-Pick disease Type C (NP-C) is a lysosomal lipid storage
disorder characterized by progressive neurodegenerative symptomatology. The signs and …

Linear clinical progression, independent of age of onset, in Niemann–Pick disease, type C

NM Yanjanin, JI Vélez, A Gropman… - American Journal of …, 2010 - Wiley Online Library
Niemann–Pick disease, type C is a neurodegenerative, lysosomal storage disorder with a
broad clinical spectrum and a variable age of onset. The absence of a universally accepted …

Recommendations on the diagnosis and management of Niemann-Pick disease type C

JE Wraith, MR Baumgartner, B Bembi… - Molecular genetics and …, 2009 - Elsevier
Niemann-Pick disease type C (NP-C) is a lysosomal storage disease in which impaired
intracellular lipid trafficking leads to excess storage of cholesterol and glycosphingolipids in …

Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry

MC Patterson, E Mengel, MT Vanier… - Orphanet journal of rare …, 2020 - Springer
Abstract Background Niemann-Pick disease Type C (NP-C) is a rare, progressive
neurodegenerative disorder characterized by progressive neurodegeneration and …